Cambrex Corporation Stock Price and Value Analysis

Should you buy Cambrex Corporation stock? (NYSE:CBM). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company is not making money.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

CBM Free Cash Flow Trend

Hmm, we can't give any reliable projection for Cambrex Corporation's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for CBM
Free Cash Flow trendline for Cambrex Corporation

Inside the CBM Numbers

CBM Price
(Cambrex Corporation stock price per share)
[?] PE Ratio versus Sector 9% lower than other Healthcare stocks
[?] PE Ratio versus Industry 68% lower than other Biotechnology stocks
[?] Cash Yield 1.18%
[?] Free Cash Flow Jitter 60%

Is Cambrex Corporation Stock on Sale?

Based on our analysis, we believe that you should not buy Cambrex Corporation right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy CBM Stock?

Does Cambrex Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.